Therapeutic monoclonal antibodies

Articles

• infliximab
  11 June 2007

  Remicade Wikipedia
  Definition: Infliximab (Remicade) is an antibody that blocks the effects of tumor necrosis factor alpha (TNF alpha or TNFA). Infliximab is administered by intervenous infusion.
  There are two other injectable drugs that block TNF alpha—adalimumab(Humira) and etanercept (Enbrel). TNF is a substance made by cells of the body which has an important role in promoting inflammation.
  Specifically, infliximab is used for treating the inflammation of Crohn’s disease, (...)

• durvalumab
  9 June 2016

  Imfinzi WP
  Durvalumab is one of PD-L1 inhibitors . It ismonoclonal antibody being investigated for the treatment of cancer. It targets programmed death ligand-1 (PD-L1), developed by MedImmune.
  Clinical trials
  non-small cell lung cancer (NSCLC) - trial combining durvalumab and gefitinib in NSCLC
  advanced metastatic urothelial bladder
  See also
  PD-L1 inhibitors
  immune (...)